Dye & Durham (DND) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
26 Nov, 2025Executive summary
Q3 FY2025 revenue reached CAD 108.3 million, up 1% year-over-year, with adjusted EBITDA of CAD 55.2 million and a margin of 51%.
Net loss for the quarter was approximately CAD 22 million, while leveraged free cash flow rebounded to CAD 24.5 million from negative CAD 7.1 million in the prior year.
Organic revenue declined 2% year-over-year, reflecting challenges in core segments and timing of prior year contracts.
A new customer-focused strategy was launched under new board and interim CEO, emphasizing customer trust, product transformation, and portfolio optimization.
Customer engagement and retention improved, with gross retention on contract renewals over 85% and regional leadership focus, notably in the U.K.
Financial highlights
Annual recurring revenue (ARR) rose to CAD 153.9 million, up CAD 28.4 million year-over-year, representing 36% of total revenue.
Annual contracted revenue (ACR) made up 61% of total revenue, up from 53% a year ago.
Adjusted net income per share was CAD 0.14, down from CAD 0.19 in the prior year.
Capex as a percentage of revenue was 6% for the last twelve months ending March 2025.
Net debt stood at approximately CAD 1.35 billion as of March 31, 2025.
Outlook and guidance
Long-term organic revenue growth is targeted in the high single-digit range, with adjusted EBITDA margin expected to remain in the 50–55% range.
Portfolio optimization, including non-core divestitures, is expected to conclude by end of fiscal 2026, with proceeds used to reduce leverage.
Over the next 12 months, acquisition, restructuring, and other costs are expected to decrease by over CAD 40 million, and net interest payments by CAD 5–10 million.
EBITDA cash flow conversion target is 85%+.
Leverage reduction to below 3x net debt/EBITDA is a key focus.
Latest events from Dye & Durham
- Revenue and EBITDA declined, but transformation and cost-saving plans target long-term growth.DND
Q2 202617 Feb 2026 - Board reconstituted, directors elected, auditor reappointed, and executive pay vote failed.DND
AGM 20243 Feb 2026 - Record Q4 revenue, 57% EBITDA margin, and ARR growth drive strong cash flow and outlook.DND
Q4 202422 Jan 2026 - ARR up 43%, strong cash flow drove debt reduction and a new dividend in Q1 FY2025.DND
Q1 202515 Jan 2026 - Q2 FY2025 revenue up 10%, ARR up 36%, and focus shifts to organic growth and efficiency.DND
Q2 202523 Dec 2025 - Revenue and EBITDA fell, but cost savings and asset sales aim to restore growth and liquidity.DND
Q4 2025 & Q1 202621 Nov 2025